A

Abgenix, Inc.

Application Filed: 2001-05-11
Trademark Application Details
Trademark Logo A

Mark For: A® trademark registration is intended to cover the categories of pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases. [all]

Status

2022-08-30 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.


Research OneLook Acronym Finder
Serial Number76255557
Registration Number2525104
Mark Literal ElementsA
Mark Drawing Type3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark TypeTRADEMARK
Standard Character ClaimNo
RegisterPRINCIPAL
Current LocationSCANNING ON DEMAND 2007-04-23
Basis1(a)
Class StatusSECTION 8 - CANCEL
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseYes
Current UseYes
Intent To UseNo
Filed ITUNo
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Cancellation Code2
Attorney NameBeth M. Goldman
Law Office AssignedM40
Employee NameVAN HORN, TAWANDA

Timeline

1997-12-29Date of First Use
1997-12-29Date of Use In Commerce
2001-05-11Application Filed
2001-10-09Published
2001-10-09Published for Opposition
2002-01-01Trademark Registered
2007-04-23Location: SCANNING ON DEMAND
2008-10-04Cancelled
2008-10-04Status: Dead/Cancelled
2008-10-04Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
2018-07-08Transaction Date

Trademark Parties (Applicants & Owners)

Party: Abgenix, Inc.
Address6701 Kaiser Drive Fremont, CALIFORNIA UNITED STATES 94555
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

Application2001-05-11
Drawing2001-05-11
Specimen2001-05-11
Registration Certificate2002-01-01
Registration Certificate2002-01-01
File Jacket2007-04-16
Specimen2007-04-16
Unclassified2007-04-16

Design Search Codes

260321Ovals that are completely or partially shaded

Attorney of Record

BETH M. GOLDMAN
HELLER EHRMAN WHITE & MCAULIFFE LLP
333 BUSH ST
SAN FRANCISCO CA 94104-2806

Good, Services, and Codes

(CANCELLED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases. FIRST USE: 19971229. FIRST USE IN COMMERCE: 19971229

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases

Trademark Filing History

DescriptionDateProceeding Number
CANCELLED SEC. 8 (6-YR)2008-10-04
CASE FILE IN TICRS2007-04-23
REGISTERED-PRINCIPAL REGISTER2002-01-01
PUBLISHED FOR OPPOSITION2001-10-09
NOTICE OF PUBLICATION2001-09-19
APPROVED FOR PUB - PRINCIPAL REGISTER2001-08-25
ASSIGNED TO EXAMINER2001-08-0978375
ASSIGNED TO EXAMINER2001-08-0378306

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed